LEXX - Lexaria Bioscience Corp.

1.33
-0.070   -5.263%

Share volume: 53,664
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$1.40
-0.07
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 35%
Dept financing 8%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.67%
1 Month
-0.75%
3 Months
-38.43%
6 Months
-55.29%
1 Year
-50.74%
2 Year
-43.40%
Key data
Stock price
$1.33
P/E Ratio 
0.00
DAY RANGE
$1.31 - $1.61
EPS 
-$0.43
52 WEEK RANGE
$1.15 - $4.41
52 WEEK CHANGE
-$50.00
MARKET CAP 
36.301 M
YIELD 
N/A
SHARES OUTSTANDING 
15.810 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
1.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$77,297
AVERAGE 30 VOLUME 
$101,272
Company detail
CEO: Christopher A. Bunka
Region: US
Website: www.lexariabioscience.com
Employees: 7
IPO year: 2009
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x.

Recent news
loading